FOLD logo

Amicus Therapeutics, Inc. (FOLD) Free Cash Flow

Annual FCF:

-$37.44M+$39.09M(+51.07%)
December 31, 2024

Summary

  • As of today, FOLD annual free cash flow is -$37.44 million, with the most recent change of +$39.09 million (+51.07%) on December 31, 2024.
  • During the last 3 years, FOLD annual free cash flow has risen by +$168.93 million (+81.86%).
  • FOLD annual free cash flow is now -357.83% below its all-time high of $14.52 million, reached on December 31, 2007.

Performance

FOLD Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDcash flow metrics

Quarterly FCF:

-$28.93M-$36.48M(-483.37%)
June 30, 2025

Summary

  • As of today, FOLD quarterly free cash flow is -$28.93 million, with the most recent change of -$36.48 million (-483.37%) on June 30, 2025.
  • Over the past year, FOLD quarterly free cash flow has dropped by -$50.52 million (-233.97%).
  • FOLD quarterly free cash flow is now -168.52% below its all-time high of $42.22 million, reached on December 31, 2007.

Performance

FOLD Quarterly Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDcash flow metrics

TTM FCF:

-$48.91M-$50.52M(-3141.92%)
June 30, 2025

Summary

  • As of today, FOLD TTM free cash flow is -$48.91 million, with the most recent change of -$50.52 million (-3141.92%) on June 30, 2025.
  • Over the past year, FOLD TTM free cash flow has dropped by -$816.00 thousand (-1.70%).
  • FOLD TTM free cash flow is now -343.94% below its all-time high of $20.05 million, reached on June 30, 2008.

Performance

FOLD TTM Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDcash flow metrics

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

FOLD Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+51.1%-234.0%-1.7%
3Y3 Years+81.9%-78.4%+71.6%
5Y5 Years+86.2%+16.4%+80.8%

FOLD Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+81.9%-234.0%+65.3%-3141.9%+71.3%
5Y5-Yearat high+86.2%-234.0%+65.3%-3141.9%+80.8%
All-TimeAll-Time-357.8%+87.8%-168.5%+78.6%-343.9%+85.6%

FOLD Free Cash Flow History

DateAnnualQuarterlyTTM
Jun 2025
-
-$28.93M(-483.4%)
-$48.91M(-3141.9%)
Mar 2025
-
$7.55M(+279.5%)
$1.61M(+104.3%)
Dec 2024
-$37.44M(+51.1%)
-$4.20M(+82.0%)
-$37.44M(-18.8%)
Sep 2024
-
-$23.33M(-208.0%)
-$31.51M(+34.5%)
Jun 2024
-
$21.59M(+168.5%)
-$48.10M(+45.4%)
Mar 2024
-
-$31.51M(-1924.3%)
-$88.03M(-15.0%)
Dec 2023
-$76.53M(+55.1%)
$1.73M(+104.3%)
-$76.53M(+52.7%)
Sep 2023
-
-$39.91M(-117.7%)
-$161.71M(-21.3%)
Jun 2023
-
-$18.34M(+8.4%)
-$133.28M(-1.6%)
Mar 2023
-
-$20.01M(+76.0%)
-$131.17M(+23.0%)
Dec 2022
-$170.34M(+17.5%)
-$83.45M(-626.3%)
-$170.34M(-7.0%)
Sep 2022
-
-$11.49M(+29.2%)
-$159.17M(+7.6%)
Jun 2022
-
-$16.22M(+72.6%)
-$172.27M(+10.4%)
Mar 2022
-
-$59.19M(+18.1%)
-$192.34M(+6.8%)
Dec 2021
-$206.38M(+12.7%)
-$72.27M(-193.9%)
-$206.38M(-11.6%)
Sep 2021
-
-$24.59M(+32.2%)
-$184.99M(+8.7%)
Jun 2021
-
-$36.29M(+50.4%)
-$202.69M(-0.8%)
Mar 2021
-
-$73.22M(-43.9%)
-$200.99M(+15.0%)
Dec 2020
-$236.52M(+12.5%)
-$50.89M(-20.3%)
-$236.52M(+7.0%)
Sep 2020
-
-$42.29M(-22.3%)
-$254.38M(+6.3%)
Jun 2020
-
-$34.59M(+68.2%)
-$271.62M(+8.8%)
Mar 2020
-
-$108.75M(-58.2%)
-$297.69M(-10.1%)
Dec 2019
-$270.43M(+11.7%)
-$68.76M(-15.5%)
-$270.43M(-2.4%)
Sep 2019
-
-$59.53M(+1.8%)
-$264.08M(+22.3%)
Jun 2019
-
-$60.65M(+25.6%)
-$340.01M(-0.8%)
Mar 2019
-
-$81.49M(-30.6%)
-$337.41M(-10.2%)
Dec 2018
-$306.26M(-39.2%)
-$62.41M(+53.9%)
-$306.26M(+3.9%)
Sep 2018
-
-$135.45M(-133.3%)
-$318.72M(-36.0%)
Jun 2018
-
-$58.06M(-15.3%)
-$234.34M(-6.6%)
Mar 2018
-
-$50.34M(+32.8%)
-$219.75M(+0.1%)
Dec 2017
-$220.01M(-40.6%)
-$74.87M(-46.6%)
-$220.01M(-23.9%)
Sep 2017
-
-$51.08M(-17.5%)
-$177.56M(-5.5%)
Jun 2017
-
-$43.46M(+14.1%)
-$168.27M(-5.6%)
Mar 2017
-
-$50.60M(-56.1%)
-$159.27M(-1.8%)
Dec 2016
-$156.49M(-49.1%)
-$32.42M(+22.4%)
-$156.49M(+3.5%)
Sep 2016
-
-$41.79M(-21.3%)
-$162.15M(-14.0%)
Jun 2016
-
-$34.47M(+27.9%)
-$142.19M(-8.5%)
Mar 2016
-
-$47.81M(-25.6%)
-$131.04M(-24.9%)
Dec 2015
-$104.96M
-$38.08M(-74.4%)
-$104.96M(-28.9%)
DateAnnualQuarterlyTTM
Sep 2015
-
-$21.83M(+6.3%)
-$81.43M(-8.9%)
Jun 2015
-
-$23.31M(-7.3%)
-$74.78M(-18.0%)
Mar 2015
-
-$21.73M(-49.3%)
-$63.38M(-22.1%)
Dec 2014
-$51.91M(-11.7%)
-$14.55M(+4.1%)
-$51.91M(-14.0%)
Sep 2014
-
-$15.18M(-27.5%)
-$45.52M(-3.6%)
Jun 2014
-
-$11.91M(-16.1%)
-$43.92M(-3.4%)
Mar 2014
-
-$10.26M(-25.6%)
-$42.48M(+8.6%)
Dec 2013
-$46.49M(-22.1%)
-$8.17M(+39.9%)
-$46.49M(-1.4%)
Sep 2013
-
-$13.58M(-29.8%)
-$45.85M(-15.5%)
Jun 2013
-
-$10.46M(+26.7%)
-$39.70M(+3.7%)
Mar 2013
-
-$14.27M(-89.5%)
-$41.22M(-8.3%)
Dec 2012
-$38.07M(+25.1%)
-$7.53M(-1.4%)
-$38.07M(+13.6%)
Sep 2012
-
-$7.43M(+38.0%)
-$44.08M(+11.6%)
Jun 2012
-
-$11.99M(-7.8%)
-$49.86M(-2.6%)
Mar 2012
-
-$11.12M(+17.9%)
-$48.59M(+4.4%)
Dec 2011
-$50.84M(-253.9%)
-$13.54M(-2.6%)
-$50.84M(-236.2%)
Sep 2011
-
-$13.20M(-23.2%)
-$15.12M(-16.0%)
Jun 2011
-
-$10.72M(+19.9%)
-$13.04M(+8.5%)
Mar 2011
-
-$13.38M(-160.3%)
-$14.25M(+0.8%)
Dec 2010
-$14.37M(+68.2%)
$22.18M(+299.4%)
-$14.37M(+69.6%)
Sep 2010
-
-$11.12M(+6.7%)
-$47.22M(+1.3%)
Jun 2010
-
-$11.92M(+11.7%)
-$47.85M(-1.5%)
Mar 2010
-
-$13.50M(-26.4%)
-$47.16M(-4.4%)
Dec 2009
-$45.18M(-14.3%)
-$10.68M(+9.2%)
-$45.18M(+9.3%)
Sep 2009
-
-$11.76M(-4.7%)
-$49.80M(-7.6%)
Jun 2009
-
-$11.23M(+2.5%)
-$46.28M(-5.9%)
Mar 2009
-
-$11.52M(+24.7%)
-$43.69M(-10.5%)
Dec 2008
-$39.53M(-372.2%)
-$15.30M(-86.0%)
-$39.53M(-319.7%)
Sep 2008
-
-$8.23M(+4.8%)
$17.99M(-10.3%)
Jun 2008
-
-$8.64M(-17.4%)
$20.05M(+10.8%)
Mar 2008
-
-$7.36M(-117.4%)
$18.11M(+24.7%)
Dec 2007
$14.52M(+140.4%)
$42.22M(+784.2%)
$14.52M(+152.4%)
Sep 2007
-
-$6.17M(+41.7%)
-$27.70M(-28.7%)
Jun 2007
-
-$10.59M(+3.2%)
-$21.53M(-96.8%)
Mar 2007
-
-$10.94M
-$10.94M
Dec 2006
-$35.92M(-69.7%)
-
-
Dec 2005
-$21.16M(-123.8%)
-
-
Dec 2004
-$9.46M(-90.5%)
-
-
Dec 2003
-$4.96M
-
-

FAQ

  • What is Amicus Therapeutics, Inc. annual free cash flow?
  • What is the all-time high annual free cash flow for Amicus Therapeutics, Inc.?
  • What is Amicus Therapeutics, Inc. annual free cash flow year-on-year change?
  • What is Amicus Therapeutics, Inc. quarterly free cash flow?
  • What is the all-time high quarterly free cash flow for Amicus Therapeutics, Inc.?
  • What is Amicus Therapeutics, Inc. quarterly free cash flow year-on-year change?
  • What is Amicus Therapeutics, Inc. TTM free cash flow?
  • What is the all-time high TTM free cash flow for Amicus Therapeutics, Inc.?
  • What is Amicus Therapeutics, Inc. TTM free cash flow year-on-year change?

What is Amicus Therapeutics, Inc. annual free cash flow?

The current annual free cash flow of FOLD is -$37.44M

What is the all-time high annual free cash flow for Amicus Therapeutics, Inc.?

Amicus Therapeutics, Inc. all-time high annual free cash flow is $14.52M

What is Amicus Therapeutics, Inc. annual free cash flow year-on-year change?

Over the past year, FOLD annual free cash flow has changed by +$39.09M (+51.07%)

What is Amicus Therapeutics, Inc. quarterly free cash flow?

The current quarterly free cash flow of FOLD is -$28.93M

What is the all-time high quarterly free cash flow for Amicus Therapeutics, Inc.?

Amicus Therapeutics, Inc. all-time high quarterly free cash flow is $42.22M

What is Amicus Therapeutics, Inc. quarterly free cash flow year-on-year change?

Over the past year, FOLD quarterly free cash flow has changed by -$50.52M (-233.97%)

What is Amicus Therapeutics, Inc. TTM free cash flow?

The current TTM free cash flow of FOLD is -$48.91M

What is the all-time high TTM free cash flow for Amicus Therapeutics, Inc.?

Amicus Therapeutics, Inc. all-time high TTM free cash flow is $20.05M

What is Amicus Therapeutics, Inc. TTM free cash flow year-on-year change?

Over the past year, FOLD TTM free cash flow has changed by -$816.00K (-1.70%)
On this page